Marsdeniae tenacissimae extract(MTE), commonly known as Xiao-Ai-Ping in China, is a traditional Chinese herb medicine capable of inhibiting proliferation and metastasis and boosting apoptosis in various cancer cells. However, little is known about the contribution of MTE towards tumor angiogenesis and the underlying mechanism. The present study aimed to evaluate the effects of MTE on the proliferation and apoptosis of human umbilical vein endothelial cells(HUVECs) and the molecular ism. 3-(4,5-dimethylthiazol-2-yl)-5(3-carboxymethoxyphenyl)-2-(4-sulfopheny)-2H-tetrazolium, inner salt(MTS) and PI-stained flow cytometry assays revealed that MTE dose-dependently reduced the proliferation of HUVECs by arresting cell cycle at S phase(P < 0.05). Annexin V-FITC/PI-stained flow cytometry confirmed that MTE(160 μL·m L-1) enhanced the apoptosis of HUVECs significantly(P < 0.001). Real-time quantitative RT-PCR and Western blot analyses showed an increase in Bax expression and a sharply decline in Bcl-2 expression; caspase-3 was activated simultaneously in a dose-dependent manner(P < 0.05). Further study observed the dose-dependent down-regulation of vascular endothelial growth factor(VEGF) receptor-2(VEGFR-2), P2Y6 receptor(P2Y6R), and chemokine(C-C motif) ligand 2(CCL-2), along with the activation of PKC δ and up-regulation of p53 in a dose-dependent manner in MTE-treated selected cells(P < 0.05). Collectively, the results from the present study suggested that MTE suppressed the proliferation by attenuating CCL-2-mediated VEGF/VEGFR2 interactions and promoted the apoptosis through PKCδ-induced p53-dependent mitochondrial pathway in HUVECs, supporting that MTE may be developed as a potent anti-cancer medicine. Marsdeniae tenacissimae extract (MTE), commonly known as Xiao-Ai-Ping in China, is a traditional Chinese herb medicine capable of inhibiting proliferation and metastasis and boosting apoptosis in various cancer cells. However, little is known about the contribution of MTE towards tumor angiogenesis and the underlying mechanism. The present study aimed to evaluate the effects of MTE on the proliferation and apoptosis of human umbilical vein endothelial cells (HUVECs) and the molecular ism. 3- (4,5-dimethylthiazol-2-yl) (3-carboxymethoxyphenyl) -2- (4-sulfopheny) -2H-tetrazolium, inner salt (MTS) and PI-stained flow cytometry assays that MTE dose- dependently reduced the proliferation of HUVECs by arresting cell cycle at S phase <0.05). Real-time quantitative RT-PCR and Western blot analyzes showed that MTE (160 μL · m L-1) enhanced the apoptosis of HUVECs significantly (P <0.001) an increase in Bax expression and a sharply decline Further study observed the dose-dependent down-regulation of vascular endothelial growth factor (VEGF) receptor-2 (VEGFR-2) , P2Y6 receptor (P2Y6R), and chemokine (CC motif) ligand 2 (CCL-2) along with the activation of PKC δ and up-regulation of p53 in a dose-dependent manner in MTE-treated selected cells ) Collectively, the results from the present study suggest that MTE suppressed proliferation by attenuating CCL-2-mediated VEGF / VEGFR2 interactions and promoted the apoptosis through PKC δ-induced p53-dependent mitochondrial pathway in HUVECs, supporting that MTE may developed as a potent anti-cancer medicine.